Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-018721
Filing Date
2016-08-08
Accepted
2016-08-08 17:13:10
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgyp-63016x10q.htm 10-Q 578239
2 EXHIBIT 31.1 sgyp-ex311x63016x10q.htm EX-31.1 11930
3 EXHIBIT 31.2 sgyp-ex312x63016x10q.htm EX-31.2 11953
4 EXHIBIT 32.1 sgyp-ex321x63016x10q.htm EX-32.1 6815
5 EXHIBIT 32.2 sgyp-ex322x63016x10q.htm EX-32.2 7478
  Complete submission text file 0001628280-16-018721.txt   3552686

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20160630.xml EX-101.INS 630353
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20160630.xsd EX-101.SCH 30611
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20160630_cal.xml EX-101.CAL 40512
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20160630_def.xml EX-101.DEF 163725
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgyp-20160630_lab.xml EX-101.LAB 414569
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20160630_pre.xml EX-101.PRE 256639
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 161815145
SIC: 2834 Pharmaceutical Preparations